DRUG News and Press, Bright Minds Biosciences Inc. From 01/04/22

VANCOUVER, British Columbia, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neur...

VANCOUVER, British Columbia, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neur...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Harmony Biosciences Holdings, Inc. is Set To Initiate Phase 3 Clinical Trial For Treatment Of Idiopathic Hypersomnia ” Harmony Biosciences Holdings, Inc. (...

— Hundreds of de novo patentable psychedelic-based compounds created through discovery program — — Company plans to announce lead molecule in first quarter of 2022 — VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Bright Minds Bioscienc...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Zosano Pharma Corporation (NASDAQ: ZSAN) Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System ” Zosano Phar...